Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time
2023年11月8日 - 6:01AM
AllPennyStocks.com
There are very good reasons that stocks
generally gain in value after a company receives orphan drug
designation (ODD). A
To read the full story on AllPennyStocks.com, click
here.
Nurexone Biologic (TSXV:NRX)
過去 株価チャート
から 5 2024 まで 6 2024
Nurexone Biologic (TSXV:NRX)
過去 株価チャート
から 6 2023 まで 6 2024
